Tesamorelin acetate (
Egrifta™) is a prescription medication approved to reduce excess abdominal (stomach) fat in people with
HIV who also have lipodystrophy. Lipodystrophy is a common side effect of human immunodeficiency virus (HIV) medications; it involves excessive fat accumulation around the stomach. Tesamorelin is taken by a subcutaneous injection (an injection just below the skin).
Just like any medicine, tesamorelin can cause side effects. However, not everyone who takes the drug will experience problems. Most people tolerate it quite well.
If side effects do occur, in most cases, they are minor and either require no treatment or are treated easily by you or your healthcare provider. Serious reactions are less common.
Some of the common side effects seen with tesamorelin include:
- Pain and redness at the injection site
- Muscle pain
- Fluid retention in the extremities
- Numbness.
(Click Side Effects of Tesamorelin to learn more, including potentially serious side effects you should report immediately to your healthcare provider.)